UPDATES – 2024 Medicare Part D Patient Safety Reports
April 24, 2024
No Comments
Relevant to: All Prescription Drug Plans, Medicare Advantage-Prescription Drug
Plans, Section 1876 Cost Plans, and PACE plans
Tag: PDPs
Categories
CY 2025 Part D Formulary Submission Information
April 16, 2024
No Comments
Relevant to: All Prescription Drug Plans, Medicare Advantage-Prescription Drug Plans,
Section 1876 Cost Plans, Medicare-Medicaid Plans, and PACE Organizations
Release of the Non-Renewal/Service Area Reduction Module in the Health Plan Management System
April 15, 2024
No Comments
Relevant to: All Current Medicare Advantage Organizations, Prescription Drug Plan Sponsors,
Section 1833 and 1876 Cost Plans, PACE and Medicare-Medicaid Plans
Medicare Advantage/Prescription Drug System (MARx) March 2024 Payment – INFORMATION
February 28, 2024
No Comments
Relevant to: All Medicare Advantage Organizations, Prescription Drug Plans,
Cost Plans, PACE Organizations, and Demonstrations
Promising Practices: Opioid Educational Sessions
February 9, 2024
No Comments
Relevant to: All Medicare Advantage Organizations (MAOs) and Prescription Drug Plan
Sponsors (PDPs)
Contract Year (CY) 2025 Final Part D Bidding Instructions
February 1, 2024
No Comments
Relevant to: All Prescription Drug Plans, Medicare Advantage-Prescription Drug Plans, Section 1876 Cost Plans, Medicare-Medicaid Plans, and PACE Plans
Introduction of Prescription Oral Antivirals for COVID-19 to the CommercialMarket
January 4, 2024
No Comments
Relevant to: All Prescription Drug Plans, Medicare Advantage-Prescription Drug Plans, Section 1876 Cost Plans, Medicare-Medicaid Plans, and PACE Organizations
2024 Health Equity Index Confidential Contract-level Reports
December 20, 2023
No Comments
Relevant to: MAOs, PDPs, Cost
CY 2024 Formulary Information
December 20, 2023
No Comments
Relevant to: PDPs, MA-PDPs, Cost, MMPs, PACE
Contract Year 2024 Part C and Part D Baseline Out-of-Pocket Cost Models
December 19, 2023
No Comments
Relevant to: Cost, MAOs, MMPs, PDPs